retatrutide phase2 weight loss A new weight-loss drug called is generating excitement after clinical trial participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also Retatrutide Delivers Significant Hemoglobin A1C

What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction

[published correction appears in Facial Plast Surg

[13] Neither the participant nor the health care provider knew which treatment was being given until after the trials were completed

Polycystic Ovary Syndrome (PCOS) is a complex hormonal disorder that affects millions of women around the world

The SELECT trial provided the first evidence of kidney protection with GLP-1RA treatment in individuals without diabetes, although this was a prespecified secondary endpoint

This might include eating on a schedule rather than waiting for hunger cues, since GLP-1 therapy specifically blunts those cues